What is Zacks Research's Forecast for CME Group Q4 Earnings?

CME Group Inc. (NASDAQ:CME - Free Report) - Investment analysts at Zacks Research increased their Q4 2025 earnings per share (EPS) estimates for CME Group in a report released on Thursday, April 10th. Zacks Research analyst T. De now anticipates that the financial services provider will earn $2.63 per share for the quarter, up from their previous forecast of $2.53. The consensus estimate for CME Group's current full-year earnings is $10.49 per share. Zacks Research also issued estimates for CME Group's Q4 2026 earnings at $2.87 EPS.

Several other brokerages have also recently commented on CME. Oppenheimer boosted their price target on shares of CME Group from $269.00 to $279.00 and gave the stock an "outperform" rating in a research report on Friday, April 11th. Morgan Stanley raised CME Group from an "equal weight" rating to an "overweight" rating and set a $301.00 price target for the company in a research report on Tuesday, April 8th. Raymond James raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target on the stock in a research report on Monday, March 10th. JPMorgan Chase & Co. increased their price objective on CME Group from $209.00 to $212.00 and gave the company an "underweight" rating in a report on Thursday, February 13th. Finally, Bank of America boosted their target price on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a report on Wednesday, April 2nd. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $247.47.

Remove Ads

CME Group Stock Up 1.1 %

Shares of CME stock traded up $2.96 during trading on Monday, reaching $264.35. The company's stock had a trading volume of 775,121 shares, compared to its average volume of 2,137,792. CME Group has a one year low of $190.70 and a one year high of $273.42. The business has a fifty day moving average price of $256.36 and a 200-day moving average price of $239.87. The company has a market cap of $95.26 billion, a price-to-earnings ratio of 27.36, a price-to-earnings-growth ratio of 6.76 and a beta of 0.43. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, topping analysts' consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%.

Institutional Investors Weigh In On CME Group

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Norges Bank bought a new stake in shares of CME Group during the fourth quarter worth $1,107,389,000. Price T Rowe Associates Inc. MD increased its holdings in CME Group by 89.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock worth $1,923,047,000 after purchasing an additional 3,921,278 shares in the last quarter. Raymond James Financial Inc. acquired a new position in CME Group in the 4th quarter worth about $871,063,000. GAMMA Investing LLC raised its position in CME Group by 32,941.0% in the first quarter. GAMMA Investing LLC now owns 1,858,887 shares of the financial services provider's stock valued at $493,144,000 after purchasing an additional 1,853,261 shares during the last quarter. Finally, Franklin Resources Inc. boosted its stake in shares of CME Group by 70.4% during the third quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider's stock valued at $544,157,000 after purchasing an additional 1,003,119 shares in the last quarter. 87.75% of the stock is owned by institutional investors.

Insider Buying and Selling at CME Group

In related news, Director Howard J. Siegel sold 10,000 shares of the business's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the sale, the director now directly owns 21,873 shares in the company, valued at approximately $5,686,980. The trade was a 31.37 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, COO Suzanne Sprague sold 1,500 shares of CME Group stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the completion of the transaction, the chief operating officer now directly owns 8,036 shares of the company's stock, valued at $2,063,885.88. This represents a 15.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 27,076 shares of company stock valued at $6,871,496 in the last ninety days. 0.30% of the stock is currently owned by corporate insiders.

CME Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were paid a $1.25 dividend. The ex-dividend date of this dividend was Friday, March 7th. This is an increase from CME Group's previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a yield of 1.89%. CME Group's payout ratio is 51.71%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.